Jpmorgan Chase & CO Nautilus Biotechnology, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 145,937 shares of NAUT stock, worth $224,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,937
Previous 35,603 309.9%
Holding current value
$224,742
Previous $101,000 142.57%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$1.67 - $2.96 $184,257 - $326,588
110,334 Added 309.9%
145,937 $245,000
Q3 2024

Dec 26, 2024
SELL
$2.24 - $3.08 $4,511 - $6,203
-2,014 Reduced 5.35%
35,603 $101,000
Q3 2024

Nov 08, 2024
SELL
$2.24 - $3.08 $4,511 - $6,203
-2,014 Reduced 5.35%
35,603 $101,000
Q2 2024

Dec 26, 2024
BUY
$2.22 - $3.0 $4,471 - $6,042
2,014 Added 5.66%
37,617 $88,000
Q2 2024

Aug 12, 2024
SELL
$2.22 - $3.0 $58,572 - $79,152
-26,384 Reduced 41.22%
37,617 $88,000
Q1 2024

Dec 26, 2024
BUY
$2.41 - $3.18 $68,439 - $90,305
28,398 Added 79.76%
64,001 $188,000
Q1 2024

May 10, 2024
BUY
$2.41 - $3.18 $8,201 - $10,821
3,403 Added 5.62%
64,001 $188,000
Q4 2023

Dec 26, 2024
BUY
$2.34 - $3.39 $58,488 - $84,733
24,995 Added 70.2%
60,598 $181,000
Q4 2023

Feb 12, 2024
BUY
$2.34 - $3.39 $8,920 - $12,922
3,812 Added 6.71%
60,598 $181,000
Q3 2023

Nov 14, 2023
BUY
$2.87 - $3.94 $40,610 - $55,751
14,150 Added 33.19%
56,786 $179,000
Q2 2023

Aug 11, 2023
BUY
$2.21 - $4.52 $6,066 - $12,407
2,745 Added 6.88%
42,636 $165,000
Q1 2023

May 18, 2023
BUY
$1.67 - $2.77 $60,980 - $101,146
36,515 Added 1081.61%
39,891 $110,000
Q1 2023

May 11, 2023
SELL
$1.67 - $2.77 $44,338 - $73,543
-26,550 Reduced 88.72%
3,376 $9,000
Q4 2022

Feb 13, 2023
SELL
$1.55 - $2.47 $5,676 - $9,045
-3,662 Reduced 10.9%
29,926 $54,000
Q3 2022

Nov 14, 2022
BUY
$1.96 - $3.13 $4,547 - $7,261
2,320 Added 7.42%
33,588 $71,000
Q2 2022

Aug 11, 2022
BUY
$2.64 - $4.84 $43,520 - $79,787
16,485 Added 111.51%
31,268 $85,000
Q1 2022

May 11, 2022
BUY
$3.5 - $5.3 $13,429 - $20,336
3,837 Added 35.05%
14,783 $64,000
Q4 2021

Feb 10, 2022
BUY
$4.45 - $6.21 $48,709 - $67,974
10,946 New
10,946 $57,000

Others Institutions Holding NAUT

# of Institutions
87
Shares Held
64.5M
Call Options Held
0
Put Options Held
0
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $192M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email